Literature DB >> 22003820

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

C Gälman1, B Angelin, M Rudling.   

Abstract

BACKGROUND: Bile acid (BA) synthesis is essential in cholesterol and lipid homoeostasis.
METHODS: Serum samples from 435 normal and 23 cholecystectomized subjects were obtained after overnight fasting and assayed for markers of BA and cholesterol synthesis, as well as cholesterol absorption. We determined whether BA synthesis was related to fibroblast growth factor 19 (FGF19; a circulating metabolic regulator that is thought to inhibit BA synthesis), gender, age and serum lipids.
RESULTS: Bile acid synthesis varied more than 9-fold in normal individuals and was 29% higher in men than in women. Whilst low-density lipoprotein cholesterol increased with age, BA and cholesterol synthesis were stable. BA production was positively correlated with serum triglycerides (TGs), and 35% of individuals with a high level (>95th percentile) of BA synthesis had hypertriglyceridaemia (HTG) (>95th percentile). Serum FGF19 levels varied by 7-fold in normal individuals and were related inversely to BA synthesis but were not related to gender, plasma lipids or history of cholecystectomy.
CONCLUSIONS: Bile acid synthesis has a wide inter-individual variation, is lower in women than in men and is correlated positively with serum TGs. High BA production is frequently linked to HTG. Age-related hypercholesterolaemia is not associated with changes in BA or cholesterol production, nor to an increase in cholesterol absorption. In humans, the circulating level of FGF19 may regulate hepatic BA production under fasting conditions. 2011 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22003820     DOI: 10.1111/j.1365-2796.2011.02466.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  39 in total

Review 1.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

2.  Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 3.  Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors:  Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

4.  Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.

Authors:  Jessica M Lee; Jessica R Ong; Laurent Vergnes; Thomas Q de Aguiar Vallim; Jonathan Nolan; Rita M Cantor; Julian R F Walters; Karen Reue
Journal:  J Lipid Res       Date:  2018-01-02       Impact factor: 5.922

5.  Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice.

Authors:  Tian Lan; Jamie Haywood; Paul A Dawson
Journal:  Atherosclerosis       Date:  2013-05-28       Impact factor: 5.162

Review 6.  Bile Acid Metabolism in Liver Pathobiology.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Gene Expr       Date:  2018-01-11

7.  Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.

Authors:  Ian M Johnston; Jonathan D Nolan; Sanjeev S Pattni; Richard N Appleby; Justine H Zhang; Sarah L Kennie; Gaganjit K Madhan; Sina Jameie-Oskooei; Shivani Pathmasrirengam; Jeremy Lin; Albert Hong; Peter H Dixon; Catherine Williamson; Julian R F Walters
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

Review 8.  Recycling rate of bile acids in the enterohepatic recirculation as a major determinant of whole body 75SeHCAT retention.

Authors:  A Michael Peters; Julian R F Walters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

9.  Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defect.

Authors:  Saul J Karpen; Paul A Dawson
Journal:  Hepatology       Date:  2014-11-20       Impact factor: 17.425

Review 10.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.